Pay in 4 interest-free payments of $5.31 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
In the matched cohort of 9,424 pairs of GLP-1RA and SGLT2i with a median follow-up of 2.9 (IQI, 1.6-4.8) years, there was no difference in the risk of AF between GLP-1RA and SGLT2i (Table 3 and Fig
For even bigger savings, platforms like Cuverd let you compare prices across 70,000+ pharmacies and access verified coupons
N Engl J Med 2024
The shelf life of compounded semaglutide in the fridge varies by formulation and concentration
Human red blood cells express the RNA sensor TLR7
104.1 The caregiver experience in amyotrophic lateral sclerosis (ALS): a mixed-methods study to examine the lived experience of caring for people living with ALS and to develop a novel ALS Caregiver Impact Questionnaire (ALS-CIQ) William Nowell 1 , Nadine McGale 2 , Oren Levy 1 , Sarah Wilding 2 , Phoebe Heinrich 2 , Nick Patel 1 , Jinsy Andrews 3 , Diana Rofail 1 1 Regeneron Pharmaceuticals, Inc., Tarrytown, New York, USA, 2 Modus Outcomes, Cambridge, Massachusetts, USA, 3 Department of Neurology, Colombia University, New York, USA Journal of Patient-Reported Outcomes 2026 , 10(Suppl 1) :104.1 Aims This study aimed to develop a conceptualization of the personal experience of caregivers of people living with amyotrophic lateral sclerosis (pALS), and a novel instrument to assess caregiver impact
US$ 28.53
US$ 21.35
US$ 21.58
US$ 20.27
US$ 23.07
